3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
2
Neoplasm Metastasis
1
Advanced Breast Cancer
1
Interventions
Fulvestrant
8
olaparib
4
Capecitabine
4
pyrotinib
3
Docetaxel
3
toripalimab
2
Vinorelbine
2
Trastuzumab
2
Letrozole
2
Injections
2
Goserelin
2
Alpelisib
2
vandetanib
1
trastuzumab deruxtecan
1
talazoparib
1
sacituzumab govitecan
1
pembrolizumab
1
neratinib
1
liposomal doxorubicin
1
exemestane
1
eribulin
1
dalpiciclib
1
ceralasertib
1
cediranib
1
capivasertib
1
abemaciclib
1
Tablets
1
Paclitaxel
1
Moxifloxacin
1
Lead
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Advanced Breast Cancer
×
AZD9833
×
Clear all
NCT07427394
2026-02-23
SERENA-1b
AstraZeneca
Phase 2
Not yet recruiting
24 enrolled